Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

EyePoint Pharmaceuticals Inc. buy Cantor Fitzgerald

Start price
€7.48
20.06.24 / 50%
Target price
-
20.06.25
Performance (%)
16.92%
Price
€8.75
26.07.24
Summary
This prediction is currently active. The prediction currently has a performance of 16.92%. This prediction currently runs until 20.06.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
EyePoint Pharmaceuticals Inc. 8.723% 8.723%
iShares Core DAX® 1.280% 1.027%
iShares Nasdaq 100 -2.457% -4.650%
iShares Nikkei 225® -2.006% -2.091%
iShares S&P 500 -0.662% -1.246%

Comments by Cantor_Fitzgerald for this prediction

In the thread EyePoint Pharmaceuticals Inc. diskutieren

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Ratings data for EYPT provided by MarketBeat

Stopped prediction by Cantor_Fitzgerald for EyePoint Pharmaceuticals Inc.

buy
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€10.20
14.09.23
€29.02
14.09.24
-14.22%
26.07.24

buy
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€9.00
31.08.23
€28.59
31.08.24
-2.78%
26.07.24